Pictet Asset Management (UK)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $93.7M | Buy |
904,417
+20,656
| +2% | +$1.95M | 0.1% | 232 |
|
|
2021
Q1 | $73.9M | Sell |
883,761
-78,196
| -8% | -$6.61M | 0.09% | 253 |
|
|
2020
Q4 | $87.8M | Sell |
961,957
-280,848
| -23% | -$23.3M | 0.11% | 219 |
|
|
2020
Q3 | $99.2M | Buy |
1,242,805
+6,060
| +0.5% | +$473K | 0.16% | 173 |
|
|
2020
Q2 | $85.5M | Buy |
1,236,745
+296,725
| +32% | +$21.1M | 0.15% | 182 |
|
|
2020
Q1 | $59.1M | Buy |
940,020
+220,548
| +31% | +$15.9M | 0.13% | 197 |
|
|
2019
Q4 | $55.9M | Sell |
719,472
-48,921
| -6% | -$3.82M | 0.1% | 249 |
|
|
2019
Q3 | $56.3M | Sell |
768,393
-35,421
| -4% | -$2.49M | 0.12% | 206 |
|
|
2019
Q2 | $49.5M | Sell |
803,814
-24,408
| -3% | -$1.48M | 0.11% | 231 |
|
|
2019
Q1 | $52.8M | Buy |
828,222
+6,798
| +0.8% | +$388K | 0.12% | 230 |
|
|
2018
Q4 | $41.9M | Sell |
821,424
-36,201
| -4% | -$1.83M | 0.11% | 244 |
|
|
2018
Q3 | $49.8M | Sell |
857,625
-35,310
| -4% | -$1.73M | 0.11% | 243 |
|
|
2018
Q2 | $43.3M | Sell |
892,935
-4,545
| -0.5% | -$212K | 0.1% | 247 |
|
|
2018
Q1 | $41.7M | Sell |
897,480
-47,772
| -5% | -$2.07M | 0.1% | 259 |
|
|
2017
Q4 | $35.5M | Sell |
945,252
-19,887
| -2% | -$730K | 0.09% | 272 |
|
|
2017
Q3 | $35.2M | Buy |
965,139
+195
| +0% | +$7.44K | 0.1% | 264 |
|
|
2017
Q2 | $37M | Buy |
964,944
+209,688
| +28% | +$7.65M | 0.11% | 233 |
|
|
2017
Q1 | $23.7M | Buy |
755,256
+28,200
| +4% | +$883K | 0.08% | 319 |
|
|
2016
Q4 | $22.7M | Buy |
727,056
+115,584
| +19% | +$3.74M | 0.08% | 293 |
|
|
2016
Q3 | $24.6M | Buy |
611,472
+279,174
| +84% | +$10.5M | 0.09% | 272 |
|
|
2016
Q2 | $10.9M | Sell |
332,298
-5,100
| -2% | -$174K | 0.04% | 413 |
|
|
2016
Q1 | $9.78M | Buy |
337,398
+600
| +0.2% | +$16.6K | 0.04% | 398 |
|
|
2015
Q4 | $8.87M | Sell |
336,798
-16,500
| -5% | -$428K | 0.04% | 431 |
|
|
2015
Q3 | $8.37M | Sell |
353,298
-5,400
| -2% | -$130K | 0.04% | 434 |
|
|
2015
Q2 | $9.1M | Sell |
358,698
-8,400
| -2% | -$190K | 0.04% | 440 |
|
|
2015
Q1 | $7.75M | Buy |
367,098
+3,000
| +0.8% | +$67.3K | 0.03% | 480 |
|
|
2014
Q4 | $7.73M | Buy |
364,098
+1,698
| +0.5% | +$34.1K | 0.03% | 465 |
|
|
2014
Q3 | $6.17M | Sell |
362,400
-2,400
| -0.7% | -$37.9K | 0.03% | 482 |
|
|
2014
Q2 | $5.22M | Sell |
364,800
-7,200
| -2% | -$97.6K | 0.02% | 544 |
|
|
2014
Q1 | $4.6M | Buy |
372,000
+6,600
| +2% | +$76.2K | 0.02% | 548 |
|
|
2013
Q4 | $4M | Sell |
365,400
-9,000
| -2% | -$101K | 0.02% | 576 |
|
|
2013
Q3 | $4.34M | Buy |
374,400
+5,400
| +1% | +$63.2K | 0.02% | 548 |
|
|
2013
Q2 | $4.13M | Buy |
+369,000
| New | +$4.37M | 0.02% | 532 |
|
Other funds holding EW
Pictet Asset Management (UK)'s EW Position: Q2 2021 in Review
Pictet Asset Management (UK) increased its Edwards Lifesciences (EW) stake by 2.3% in Q2 2021, buying an estimated $1.95M and bringing the position to 904,417 shares worth $93.7M. The position accounts for 0.1% of the portfolio, ranked #232.
Pictet Asset Management (UK) first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $99.2M in Q3 2020. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.
- Pictet Asset Management (UK) held 904,417 shares of Edwards Lifesciences worth $93.7M as of Q2 2021.
- Pictet Asset Management (UK) bought 20,656 Edwards Lifesciences shares in Q2 2021, an estimated $1.95M.
- Edwards Lifesciences made up 0.1% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #232 holding.
- Pictet Asset Management (UK) first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
- Pictet Asset Management (UK)'s Edwards Lifesciences position peaked at $99.2M in Q3 2020.
- 1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.